Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Thursday, July 24, 2014
Second Question of the Day July 24, 2014 Is the next big NECC like outbreak bound to happen in a state like Texas whose state board of pharmacy appears to refuse to acknowledge there is a problem in its state, caters to the demands of compouding pharmacies, pharmacists and the groups that represent them, and fails to take any meaningful action against those who fail to follow the rules and regulations?
Subscribe to:
Post Comments (Atom)
1 comment:
Texas has already had a problem with adulterated drugs coming from their compounding pharmacies. ApotheCure killed 3 patients when they sent intravenous colchicine to Oregon (a state it didn't have a license to practice in), in which this drug was 8x overpotent. ApotheCure previously killed at least one patient with nonsterile steroids (causing meningitis, similar to NECC). Just because ApotheCure has been renamed "NuVision", doesn't mean this pharmacy isn't doing bad behaviors still. It seems the FDA conducts inspections and strongly urges NuVision to recall its unsterile drugs (which it doesn't do). When another outbreak happens, who will be held responsible? I doubt it will be the pharmacy, as they will simply "declare bankruptcy", and re-register another pharmacy and start off fresh.
Post a Comment